Several factors influence the speed of development of antibacterial resistance, among which
is the amount of antibiotic consumption. During the 3-year period 1998-2000, the …

The activities of piperacillin/tazobactam (PTZ) and 10 other β-lactams were evaluated by a
broth microdilution method using the PASCO system in 1078 Escherichia coli and 447 …

Evaluating the Appropriate Use of Piperacillin/Tazobactam in a Community Health System -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

From September 1994 to March 1995 an Italian multicenter in vitro study to evaluate the
susceptibility of piperacillin/tazobactam compared with that of imipenem, ceftazidime …

Piperacillin combined with tazobactam at a fixed concentration (4 μg/ml) and a ratio (8: 1)
was tested against 5029 aerobic isolates and 447 fastidious organisms, including …

Piperacillin/tazobactam is the most recently approved combination of a β-lactam agent with
an inhibitor of bacterial β-lactamases. It has a broader spectrum than do preceding inhibitor …

Combining tazobactam, a beta-lactamase inhibitor, with the ureidopenicillin, piperacillin,
successfully restores the activity of piperacillin against beta-lactamase producing bacteria …

We investigated knowledge, attitudes, and behaviors of prescribers concerning piperacillin-
tazobactam use at 4 Emory University-affiliated hospitals. Discussions during focus groups …

Abstract Twenty-nine British and Irish hospitals each collected up to 300 bacterial isolates
from in-patients. The organisms were identified by an appropriate API system or, for …

Piperacillin/tazobactam is a highly active antibiotic against most clinically important species
of Gram-negative and positive bacteria, including anaerobes. It has never been used or …